How Long Do You Need to Fast to Reduce Inflammation?

Most research points to daily fasts of 14 to 18 hours as the threshold where measurable drops in inflammatory markers begin to appear. But the full picture is more nuanced than a single number. How long you need to fast, how often, and what kind of results you can expect all depend on the type of fasting, how much weight you lose in the process, and which inflammatory markers you’re tracking.

The 14-to-18-Hour Window

Time-restricted feeding, where you compress all your eating into a set window each day, is the most studied form of fasting for inflammation. In clinical trials, daily fasting periods of 16 hours (with an 8-hour eating window) are the most common protocol, though some studies use 14-hour or 18-hour fasts. A large systematic review and meta-analysis of these trials found that time-restricted feeding significantly reduced TNF-alpha, one of the body’s key inflammatory signaling molecules. Protocols ranged from a 14-hour overnight fast to a 20-hour fast with just a 4-hour eating window, but the 16:8 pattern appeared most frequently.

A separate controlled study found that daily fasting significantly lowered blood levels of IL-6 and IL-1 beta, two other major inflammatory markers. The reductions were apparent at multiple time points throughout the day, and the effect on IL-6 was particularly striking: its normal daily fluctuation flattened considerably, dropping from a rhythm amplitude of 12 (before fasting) to just 2 after several weeks of practice.

These results suggest that you don’t need extreme multi-day fasts to move the needle. A consistent daily fast of roughly 16 hours, something like finishing dinner by 8 p.m. and not eating again until noon, is enough to shift inflammatory chemistry in a meaningful direction.

What Happens Inside Your Body

Fasting triggers a cascade of changes that work against inflammation through several routes at once. One key mechanism involves arachidonic acid, a fatty acid that rises in the blood during fasting. Researchers at the National Institutes of Health found that this increase in arachidonic acid directly dials down the NLRP3 inflammasome, a protein complex that acts as one of the immune system’s main alarm systems. When this alarm is overactive, it drives the chronic, low-grade inflammation linked to heart disease, type 2 diabetes, and autoimmune conditions. Fasting essentially turns down the volume on that alarm.

At the same time, fasting improves insulin sensitivity. A meta-analysis of trials in people with metabolic syndrome found that fasting significantly reduced fasting blood sugar, long-term blood sugar levels (HbA1c), and insulin resistance scores. This matters for inflammation because insulin resistance and inflammatory signaling reinforce each other. Fat tissue in someone with insulin resistance pumps out more IL-6 and other inflammatory molecules, creating a feedback loop. Breaking that loop by improving how your body handles insulin is one of fasting’s most reliable anti-inflammatory effects.

Fasting also appears to reduce fat mass, shift gut bacteria toward healthier compositions, and lower oxidative stress, all of which feed back into reduced inflammation.

Longer Fasts and Immune Cell Changes

Fasts lasting 48 hours or more produce a qualitatively different response. During prolonged fasting, the body dramatically reduces the number of monocytes and lymphocytes circulating in the blood. These immune cells retreat to the bone marrow, where they essentially wait in reserve. One study found that a 48-hour water-only fast reduced monocyte mobilization even in response to infection or wound healing.

When you eat again after a prolonged fast, these immune cells re-emerge. The refeeding phase appears to reset immune cell populations, which is why some researchers describe it as an “immune reboot.” This process has shown potential in preclinical studies for autoimmune diseases, cancer, and neurodegeneration, though the clinical evidence in humans is still developing.

Extended fasts carry real risks, though. Elevated inflammatory markers during longer fasts can increase cardiovascular or blood-clotting risk, particularly in people with atherosclerosis or those taking oral contraceptives. For most people interested in managing everyday chronic inflammation, the daily 16-hour approach is both safer and better supported by evidence.

Weight Loss Is the Hidden Variable

One of the most important findings in this research is that fasting’s effect on certain inflammatory markers depends heavily on how much weight you lose. A review of human trials found that time-restricted eating with only 1 to 5% weight loss had no significant effect on CRP (C-reactive protein, a widely used marker of systemic inflammation), TNF-alpha, or IL-6. The fasting window didn’t seem to matter much, whether it was 4 hours or 10 hours, if weight loss was minimal.

The picture changed dramatically with greater weight loss. In alternate-day fasting trials where participants lost 6% or more of their body weight, CRP dropped by 13 to 48%. In one trial, alternate-day fasting reduced CRP by 48%, nearly double the 25% reduction seen with standard calorie restriction producing similar weight loss. This suggests fasting may have anti-inflammatory advantages beyond simple calorie reduction, but those advantages become visible only when paired with meaningful fat loss.

If your primary goal is lowering CRP, the evidence is clear: the fasting protocol matters less than whether it helps you sustain enough of a calorie deficit to lose a significant amount of weight over weeks to months.

Which Inflammatory Markers Respond to What

Not all markers respond the same way to every type of fasting, and understanding this can help you set realistic expectations.

  • TNF-alpha: Intermittent fasting (time-restricted eating patterns) significantly reduces this marker. A pooled analysis of randomized controlled trials found a meaningful decrease in TNF-alpha specifically with intermittent fasting, not with simple calorie restriction.
  • IL-6: This marker responds to both intermittent fasting and calorie restriction. Controlled studies show significant reductions during fasting periods, with one meta-analysis confirming a statistically significant drop across multiple trials. IL-6 is closely tied to insulin resistance and excess body fat, so improvements in metabolic health amplify the effect.
  • CRP: The most stubborn marker to move. Calorie restriction lowers it modestly, but intermittent fasting alone (without substantial weight loss) does not reliably reduce CRP. Alternate-day fasting with at least 6% weight loss is the protocol most consistently linked to CRP reductions.

If you’re getting blood work done to track your progress, CRP and IL-6 are the most commonly available tests. TNF-alpha testing is less standard but can be ordered through most labs.

Practical Fasting Approaches

Based on the available evidence, here’s what different fasting durations offer for inflammation:

A 14-to-16-hour daily fast is the most practical starting point. Most trials showing reduced TNF-alpha and IL-6 used this range. It’s sustainable long-term for most people and aligns with the body’s natural overnight fasting period. Simply skipping breakfast or moving it later can get you there.

An 18-to-20-hour daily fast compresses eating into a 4-to-6-hour window. Several trials used this approach and it was included in the protocols showing significant TNF-alpha reduction. It’s more aggressive but still a daily practice rather than a multi-day event.

Alternate-day fasting, where you eat normally one day and eat very little or nothing the next, is the protocol with the strongest evidence for lowering CRP, but only when sustained long enough to produce at least 6% body weight loss. For someone weighing 200 pounds, that means losing at least 12 pounds.

Prolonged fasts of 48 hours or more produce the most dramatic immune system changes but carry more risk and have less clinical evidence supporting routine use. These should not be a starting point for someone new to fasting.

Consistency matters more than intensity. The inflammatory benefits seen in clinical trials emerged over weeks to months of regular practice, not from a single fast. The metabolic improvements that drive much of the anti-inflammatory effect, including better insulin sensitivity and reduced fat mass, are cumulative changes that build over time.